Fundz

Inozyme Pharma, Llc reported raising in an initial SEC Form D filing

RECENTLY ACQUIREDJan 05, 2017

Round Type

Venture

BostonHealthcareHealth CareTherapeuticsPharmaceutical

Quick answer

Inozyme Pharma raised an undisclosed amount in a funding round, dated January 5, 2017. Inozyme Pharma is based in Boston, Massachusetts, United States.

How much did Inozyme Pharma raise?
Inozyme Pharma raised an undisclosed amount in a funding round on January 5, 2017.
What does Inozyme Pharma do?
Inozyme Pharma is a USA-based biopharma company focused on developing innovative therapeutics for rare diseases that affect bone health and blood vessel function.
Where is Inozyme Pharma based and how big is it?
Inozyme Pharma is based in Boston, Massachusetts, United States. Fundz records about 65 employees.
Who are the decision-makers at Inozyme Pharma?
Fundz holds 1 contact at Inozyme Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Inozyme Pharma that raised within 45 days of this round, from Fundz verified event records.

  • AIM ImmunoTech raised $18K (Pre-Seed) on February 13, 2017.
  • Revolution Medicines raised $48M on December 21, 2016.
  • IRulya Therapeutics Inc. raised $7.6M on February 14, 2017.
  • Ovid Therapeutics raised $26M on January 20, 2017.
  • Rhythm Pharmaceuticals raised $20M on January 20, 2017.
  • Galectin raised $3M (Seed) on January 6, 2017.

Who to call at Inozyme Pharma, and when

A new round usually means Inozyme Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Inozyme Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Inozyme Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Inozyme Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Inozyme Pharma

Location

Boston, Massachusetts, United States

About

Inozyme Pharma is a USA-based biopharma company focused on developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. The company aims to address significant unmet needs in patients suffering from these conditions. Inozyme is publicly traded on Nasdaq under the ticker INZY.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Inozyme Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts26 people are listed at Inozyme Pharma. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Inozyme Pharma's next move

See what Strategic adds

Inozyme Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.